Vivos Therapeutics, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-2
Book Value Per Share
$-0
Free Cash Flow Per Share
$-2
Cash Per Share
$0
Revenue Per Share
$2
OCF Per Share
$-1
Return on Equity
-655.0%
Return on Assets
-104.7%
Return on Invested Capital
-394.4%
Debt to Equity
-0.51
Current Ratio
0.24
Quick Ratio
0.24
Asset Turnover
0.86
Days Sales Outstanding
33.08
Days Payables Outstanding
88.80
R&D / Revenue
0.6%
SBC / Revenue
3.8%
Capex / Revenue
13.4%
Working Capital
$-14M
Net Current Asset Value
$-22M
Invested Capital
$-737K
OCF / Net Income
0.72
FCF / Net Income
0.83
Accruals Ratio (Sloan)
-23.5%
Net Debt
$-1M
Net Debt / EBITDA
0.07
Interest Coverage
-14.21
Cash Coverage
-10.90
Capex Coverage
-6.52
Tangible Common Equity
$-14M
TCE / Total Assets
-56.1%
Goodwill / Total Assets
34.1%
NOPAT
$-16M
Cash ROIC
-441.8%
WC / Revenue
-78.5%
Capex / D&A
1.79
Reinvestment Rate
-5.2%
Asset Growth vs Revenue Growth
48.5%
Revenue 5Y CAGR
5.9%
Stock Price (FY-end)
$2
Market Cap
$21M
P/S Ratio
1.20
P/B Ratio
2.71
P/TB Ratio
4.58
Enterprise Value
$20M
EV / Sales
1.12
FCF Yield
-84.4%
Shareholder Yield
-3.2%
R&D Yield
0.5%
Capex Yield
11.2%
Shares Variation (YoY)
104.7%
Beta (5Y)
0.86
Cost of Equity
8.8%
Cost of Debt (after tax)
146.9%
52W High
$7
52W Low
$2
Trailing Return 1Y
-56.3%
Trailing Return 5Y
-98.9%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-9.08
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.